-
Product Insights
Karadeniz Powership Mehmet Bey – Mozambique
Karadeniz Powership Mehmet Bey - Mozambique is a thermal project located in Nampula, Mozambique. The project is owned and developed by Karpowership Company Ltd. The project came online in 2018. Empower your strategies with our Karadeniz Powership Mehmet Bey - Mozambique report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BEI-105 in Mitochondrial Myopathy
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.BEI-105 in Mitochondrial MyopathyDrug Details:BEI-105 is under development for the treatment of age-related diseases including mitochondrial...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BEY-1107 in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BEY-1107 in Metastatic Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.BEY-1107 in Metastatic Colorectal Cancer Drug Details:BEY-A is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BEI-103 in Glioblastoma Multiforme (GBM)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.BEI-103 in Glioblastoma Multiforme (GBM)Drug Details:BEI-103 is under development for the treatment of glioblastoma. The drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BEY-1107 in Pancreatic Ductal Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BEY-1107 in Pancreatic Ductal Adenocarcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.BEY-1107 in Pancreatic Ductal AdenocarcinomaDrug Details:BEY-A is under development for the treatment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PC-14586 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PC-14586 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PC-14586 in Solid Tumor Drug Details: PC-14586 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BEY-1107 in Recurrent Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BEY-1107 in Recurrent Glioblastoma Multiforme (GBM) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BEY-1107 in Recurrent Glioblastoma Multiforme (GBM) Drug Details: BEY-A is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AZD-5305 in Esophageal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AZD-5305 in Esophageal Cancer Drug Details: AZD-5305 is under development for the treatment of advanced...